首页 › 非小细胞肺癌 › 加利福尼亚州 › Concord
Concord CA 非小细胞肺癌临床试验
14项针对 非小细胞肺癌的研究正在 Concord及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距离 5 英里
- John Muir Medical Center-Walnut Creek, Walnut Creek · 距离 5 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距离 5 英里
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
招募中3 期
- Local Institution - 0208, Pleasant Hill · 距离 3 英里
- BASS Cancer Center, Walnut Creek · 距离 5 英里
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- John Muir Health Clinical Research Center, Concord
- John Muir Health Cancer Center, Walnut Creek · 距离 5 英里
- John Muir Health Clinical Research Center, Walnut Creek · 距离 5 英里
- 以及另外 1 项
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · 距离 5 英里
- John Muir Health Clinical Research Center, Walnut Creek · 距离 5 英里
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- BASS Cancer Center, Walnut Creek · 距离 5 英里
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
招募中观察性研究
- John Muir Health, Walnut Creek · 距离 5 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- John Muir Clinical Research Center, Concord
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
招募中3 期
- Research Site, Walnut Creek · 距离 5 英里
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- BASS Cancer Center, Walnut Creek · 距离 5 英里
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, Walnut Creek · 距离 5 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距离 5 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距离 5 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距离 5 英里
- Contra Costa Regional Medical Center, Martinez · 距离 6 英里
- Contra Costa Regional Medical Center, Martinez · 距离 6 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Concord的其他研究
- 肥胖症18 项研究
- 超重16 项研究
- 重度抑郁症12 项研究
- 2型糖尿病10 项研究
- 乳腺癌9 项研究
- 肺癌9 项研究
- 偏头痛8 项研究
- 癌症（所有类型）7 项研究
- 抑郁症6 项研究
- 前列腺癌6 项研究
- 糖尿病5 项研究
- 阿尔茨海默病5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。